SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-019579
Filing Date
2023-12-07
Accepted
2023-12-07 07:45:19
Documents
13
Period of Report
2023-12-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xlo-20231207x8k.htm   iXBRL 8-K 49871
2 EX-99.1 xlo-20231207xex99d1.htm EX-99.1 30881
  Complete submission text file 0001558370-23-019579.txt   214415

Data Files

Seq Description Document Type Size
3 EX-101.SCH xlo-20231207.xsd EX-101.SCH 3115
4 EX-101.LAB xlo-20231207_lab.xml EX-101.LAB 16579
5 EX-101.PRE xlo-20231207_pre.xml EX-101.PRE 10709
7 EXTRACTED XBRL INSTANCE DOCUMENT xlo-20231207x8k_htm.xml XML 5045
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Filer) CIK: 0001840233 (see all company filings)

IRS No.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40925 | Film No.: 231471083
SIC: 2834 Pharmaceutical Preparations